Evidence map›Paper›PMID 28179010›Full record

ArticleVirology journal2017

Characterization and complete genome of the virulent Myoviridae phage JD007 active against a variety of Staphylococcus aureus isolates from different hospitals in Shanghai, China.

Zelin Cui, Tingting Feng, Feifei Gu, Qingtian Li, Ke Dong, Yan Zhang, Yongzhang Zhu, Lizhong Han, Jinhong Qin, Xiaokui Guo

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Isolation and characterization of novelFrontiers in microbiology · 2022
    Article
  15. Article
  16. JD419, aFrontiers in microbiology · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Zelin CuiDepartment of Immunology and Microbiology, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China. czl_phage@126.com.
Tingting FengDepartment of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Feifei GuDepartment of Clinical Microbiology, Shanghai Ruijin hospital, Shanghai, 200025, China.
Qingtian LiDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Ke DongDepartment of Immunology and Microbiology, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China.
Yan ZhangDepartment of Immunology and Microbiology, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China.
Yongzhang ZhuDepartment of Immunology and Microbiology, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China.
Lizhong HanDepartment of Clinical Microbiology, Shanghai Ruijin hospital, Shanghai, 200025, China.
Jinhong QinDepartment of Immunology and Microbiology, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China.
Xiaokui GuoDepartment of Immunology and Microbiology, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China. microbioloy@sjtu.edu.cn.
Shanghai Jiao Tong University · CNRuijin Hospital · CNShanghai First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe implementation of phage therapy is re-emerging with the increase in widespread antibiotic-resistant bacteria.

methodsStaphylococcus phage JD007 was characterized and its complete genome sequence analysed.

resultsStaphylococcus phage JD007 was classified as belonging to the Myoviridae family based on its morphology, as observed by transmission electron microscopy. Its lytic activity was stable between pH 5-11 and below 42 °C; moreover, an absorbance curve showed that nearly 90% of the viral particles had adsorbed to its host after a 20 min co-incubation. The complete genome size is 141,836 bp, making JD007 one of the largest Staphylococcus phages of Myoviridae. No identifiable resistance or virulence genes were found in the JD007 genome. JD007 was able to lyse 95% of S. aureus isolates, including the prevalent ST239-MRSA and ST59-MRSA strains isolated from different hospitals in Shanghai, China, and inhibition assays showed that JD007 could inhibit S. aureus growth at a multiplicity of infection of 0.1.

conclusionsThe results suggested that Staphylococcus phage JD007 can potentially be used in phage therapy or for the detection of S. aureus.

Indexed as

Genome, ViralHost SpecificityChinaCross InfectionDNA, ViralHumansHydrogen-Ion ConcentrationMicrobial ViabilityMicroscopy, Electron, TransmissionMyoviridaeSequence Analysis, DNAStaphylococcal InfectionsStaphylococcus aureusStaphylococcus PhagesTemperatureVirionDNA, ViralHost-rangeMRSAStaphylococcus phage JD007

Identifiers

PMID28179010
PMCPMC5299689
OpenAlexW2587003224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.